- Home
- BJDX vs AEMD Comparison
BJDX vs AEMD Comparison
Compare BJDX & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BJDX | AEMD |
|---|---|---|
| Founded | 2015 | 1984 |
| Country | | US |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.1M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | BJDX | AEMD |
|---|---|---|
| Price | $1.99 | $2.04 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $287.50 |
| AVG Volume (30 Days) | ★ 155.9K | 53.0K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $55.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $0.31 |
| 52 Week High | $10.20 | $5.89 |
Technical Indicators
Market Signals| Indicator | BJDX | AEMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.21 | 36.34 |
| Support Level | $2.84 | $1.93 |
| Resistance Level | $3.60 | $2.19 |
| Average True Range (ATR) | 0.45 | 0.18 |
| MACD | -0.13 | -0.01 |
| Stochastic Oscillator | 6.53 | 18.21 |
Price Performance
Historical ComparisonAbout BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.